Medicine Description diacurimap 25mg
diacurimap tablets to regulate blood sugar level is a medication that combines empagliflozin and metformin, working synergistically to manage blood glucose levels in individuals with type II diabetes. Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption in the kidneys, promoting urinary glucose excretion. This results in lowered blood sugar levels. Metformin, on the other hand, enhances insulin sensitivity, decreases hepatic glucose production, and improves glucose uptake by peripheral tissues. Together, these mechanisms help control hyperglycemia and improve metabolic function in diabetic patients.
Indications and Uses of diacurimap tablets to regulate blood sugar level
- Management of type II diabetes mellitus as an adjunct to diet and exercise.
- Used in patients for whom metformin alone does not provide adequate glycemic control.
- Assists in the reduction of cardiovascular risk factors in individuals with type II diabetes and established cardiovascular disease.
Side Effects of diacurimap tablets to regulate blood sugar level
- Nausea and vomiting
- Diarrhea
- Abdominal pain
- Increased risk of urinary tract infections
- Potential for ketoacidosis
- Hypoglycemia when combined with other antidiabetic agents
Storage and Handling
Store diacurimap tablets in a cool, dry place away from direct sunlight and moisture. Ensure that the medication is kept out of reach of children.
Patient Advice and Precautions
Patients should be advised to monitor their blood sugar levels regularly and report any unusual symptoms. It is crucial to maintain a balanced diet and an active lifestyle. Hydration is important, especially when taking this medication due to increased urination. Patients should discuss any existing medical conditions or medications with their healthcare provider to avoid potential interactions.